The co-founder of the fintech startup Yotta, Adam Moelis, set out with the noble intention of providing Americans with a new way to save money. Unfortunately, what started as a promising endeavor has now turned into a nightmare for thousands of customers. A dispute between Yotta’s banking partners, Synapse and Evolve Bank & Trust, has
admin
Pfizer’s groundbreaking drug, Lorbrena, has demonstrated revolutionary progress in the treatment of advanced non-small cell lung cancer. Recent long-term results from a late-stage trial have showcased the drug’s ability to significantly extend the lifespan of patients while preventing the progression of cancer. With a remarkable data showing that most individuals experienced positive outcomes for over
In recent years, many companies have been shifting their focus when it comes to hiring practices. Rather than placing a heavy emphasis on traditional metrics such as education or years of experience, companies are now prioritizing applicants’ skills. This shift is evident in the decreasing number of job postings that list specific requirements for employment
When it comes to retirement planning, higher earners often face limitations on tax-free savings options. The traditional Roth IRA, known for its tax-free growth benefits, has income limits that disqualify some individuals from making direct contributions. For single filers, the adjusted gross income limit for Roth IRA contributions in 2024 is $161,000, while for married